LEMAITRE VASCULAR INC (LMAT) Stock Fundamental Analysis
NASDAQ:LMAT - Nasdaq - US5255582018 - Common Stock - Currency: USD
LMAT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. LMAT gets an excellent profitability rating and is at the same time showing great financial health properties. LMAT has a correct valuation and a medium growth rate. With these ratings, LMAT could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year LMAT was profitable.
In the past year LMAT had a positive cash flow from operations.
In the past 5 years LMAT has always been profitable.
In the past 5 years LMAT always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of LMAT (7.98%) is better than 88.89% of its industry peers.
The Return On Equity of LMAT (13.06%) is better than 88.36% of its industry peers.
LMAT has a Return On Invested Capital of 7.70%. This is amongst the best in the industry. LMAT outperforms 86.77% of its industry peers.
LMAT had an Average Return On Invested Capital over the past 3 years of 8.26%. This is in line with the industry average of 7.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.98% | ||
| ROE | 13.06% | ||
| ROIC | 7.7% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
LMAT's Profit Margin of 20.03% is amongst the best of the industry. LMAT outperforms 93.12% of its industry peers.
LMAT's Profit Margin has improved in the last couple of years.
LMAT's Operating Margin of 23.77% is amongst the best of the industry. LMAT outperforms 94.71% of its industry peers.
LMAT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 68.63%, LMAT is in the better half of the industry, outperforming 75.66% of the companies in the same industry.
In the last couple of years the Gross Margin of LMAT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.77% | ||
| PM (TTM) | 20.03% | ||
| GM | 68.63% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), LMAT is destroying value.
The number of shares outstanding for LMAT has been increased compared to 1 year ago.
Compared to 5 years ago, LMAT has more shares outstanding
Compared to 1 year ago, LMAT has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 6.86 indicates that LMAT is not in any danger for bankruptcy at the moment.
The Altman-Z score of LMAT (6.86) is better than 86.24% of its industry peers.
LMAT has a debt to FCF ratio of 4.51. This is a neutral value as LMAT would need 4.51 years to pay back of all of its debts.
LMAT has a Debt to FCF ratio of 4.51. This is amongst the best in the industry. LMAT outperforms 83.07% of its industry peers.
LMAT has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of LMAT (0.50) is worse than 60.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 4.51 | ||
| Altman-Z | 6.86 |
ROIC/WACC0.88
WACC8.74%
2.3 Liquidity
A Current Ratio of 13.14 indicates that LMAT has no problem at all paying its short term obligations.
LMAT has a Current ratio of 13.14. This is amongst the best in the industry. LMAT outperforms 97.35% of its industry peers.
LMAT has a Quick Ratio of 11.02. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
LMAT's Quick ratio of 11.02 is amongst the best of the industry. LMAT outperforms 96.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.14 | ||
| Quick Ratio | 11.02 |
3. Growth
3.1 Past
LMAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.13%, which is quite impressive.
LMAT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.13% yearly.
The Revenue has grown by 13.63% in the past year. This is quite good.
LMAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.41% yearly.
EPS 1Y (TTM)31.13%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%9.09%
Revenue 1Y (TTM)13.63%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.95%
3.2 Future
The Earnings Per Share is expected to grow by 9.98% on average over the next years. This is quite good.
Based on estimates for the next years, LMAT will show a quite strong growth in Revenue. The Revenue will grow by 8.51% on average per year.
EPS Next Y17.62%
EPS Next 2Y13.98%
EPS Next 3Y12.67%
EPS Next 5Y9.98%
Revenue Next Year8.69%
Revenue Next 2Y8.59%
Revenue Next 3Y8.74%
Revenue Next 5Y8.51%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 40.98, which means the current valuation is very expensive for LMAT.
LMAT's Price/Earnings ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 70.37% of the companies in the same industry.
When comparing the Price/Earnings ratio of LMAT to the average of the S&P500 Index (28.18), we can say LMAT is valued slightly more expensively.
The Price/Forward Earnings ratio is 32.19, which means the current valuation is very expensive for LMAT.
Based on the Price/Forward Earnings ratio, LMAT is valued a bit cheaper than the industry average as 72.49% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.81, LMAT is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.98 | ||
| Fwd PE | 32.19 |
4.2 Price Multiples
LMAT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 73.02% of the companies in the same industry.
LMAT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 74.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 49.32 | ||
| EV/EBITDA | 22.15 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
LMAT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as LMAT's earnings are expected to grow with 12.66% in the coming years.
PEG (NY)2.33
PEG (5Y)2.39
EPS Next 2Y13.98%
EPS Next 3Y12.67%
5. Dividend
5.1 Amount
LMAT has a Yearly Dividend Yield of 1.02%. Purely for dividend investing, there may be better candidates out there.
LMAT's Dividend Yield is rather good when compared to the industry average which is at 1.85. LMAT pays more dividend than 93.12% of the companies in the same industry.
With a Dividend Yield of 1.02, LMAT pays less dividend than the S&P500 average, which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.02% |
5.2 History
The dividend of LMAT is nicely growing with an annual growth rate of 13.60%!
LMAT has paid a dividend for at least 10 years, which is a reliable track record.
LMAT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
32.65% of the earnings are spent on dividend by LMAT. This is a low number and sustainable payout ratio.
LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP32.65%
EPS Next 2Y13.98%
EPS Next 3Y12.67%
NASDAQ:LMAT (5/5/2025, 3:29:07 PM)
81.14
+2.44 (+3.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners96.19%
Inst Owner Change-2.08%
Ins Owners8.87%
Ins Owner Change-0.1%
Market Cap1.83B
Analysts76.47
Price Target107.74 (32.78%)
Short Float %6.35%
Short Ratio5.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.02% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP32.65%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.97%
Min EPS beat(2)-2.5%
Max EPS beat(2)10.44%
EPS beat(4)3
Avg EPS beat(4)6.87%
Min EPS beat(4)-2.5%
Max EPS beat(4)11.39%
EPS beat(8)7
Avg EPS beat(8)6.94%
EPS beat(12)7
Avg EPS beat(12)-0.55%
EPS beat(16)9
Avg EPS beat(16)-0.6%
Revenue beat(2)1
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)0.45%
Revenue beat(4)2
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.79%
Revenue beat(8)4
Avg Revenue beat(8)0.38%
Revenue beat(12)5
Avg Revenue beat(12)-0.29%
Revenue beat(16)6
Avg Revenue beat(16)-0.46%
PT rev (1m)0%
PT rev (3m)6.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.16%
EPS NY rev (1m)0%
EPS NY rev (3m)3.25%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.98 | ||
| Fwd PE | 32.19 | ||
| P/S | 8.34 | ||
| P/FCF | 49.32 | ||
| P/OCF | 41.54 | ||
| P/B | 5.43 | ||
| P/tB | 7.78 | ||
| EV/EBITDA | 22.15 |
EPS(TTM)1.98
EY2.44%
EPS(NY)2.52
Fwd EY3.11%
FCF(TTM)1.65
FCFY2.03%
OCF(TTM)1.95
OCFY2.41%
SpS9.73
BVpS14.93
TBVpS10.43
PEG (NY)2.33
PEG (5Y)2.39
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.98% | ||
| ROE | 13.06% | ||
| ROCE | 10.03% | ||
| ROIC | 7.7% | ||
| ROICexc | 18.13% | ||
| ROICexgc | 33.54% | ||
| OM | 23.77% | ||
| PM (TTM) | 20.03% | ||
| GM | 68.63% | ||
| FCFM | 16.9% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexcg growth 3Y-0.4%
ROICexcg growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 4.51 | ||
| Debt/EBITDA | 2.71 | ||
| Cap/Depr | 72% | ||
| Cap/Sales | 3.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.25% | ||
| Profit Quality | 84.39% | ||
| Current Ratio | 13.14 | ||
| Quick Ratio | 11.02 | ||
| Altman-Z | 6.86 |
F-Score5
WACC8.74%
ROIC/WACC0.88
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)31.13%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%9.09%
EPS Next Y17.62%
EPS Next 2Y13.98%
EPS Next 3Y12.67%
EPS Next 5Y9.98%
Revenue 1Y (TTM)13.63%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.95%
Revenue Next Year8.69%
Revenue Next 2Y8.59%
Revenue Next 3Y8.74%
Revenue Next 5Y8.51%
EBIT growth 1Y40.49%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year40.88%
EBIT Next 3Y20.71%
EBIT Next 5YN/A
FCF growth 1Y26.03%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y20.06%
OCF growth 3Y7.93%
OCF growth 5Y25.49%